Assessing Cancer Registry Systems: Challenges and Opportunities for Improving Outreach in Rhode...
-
Upload
kaitlyn-biers -
Category
Documents
-
view
219 -
download
0
Transcript of Assessing Cancer Registry Systems: Challenges and Opportunities for Improving Outreach in Rhode...
Assessing Cancer Registry Systems: Challenges and Opportunities for Improving Outreach in Rhode Island Minority Populations
The Rhode Island Latino Cancer Control Task Force (LCCTF)
Bridging the Health Care Divide: Research and Programs to Eliminate Cancer Disparities
American Cancer Society Conference New Orleans, Louisiana
April 18-20, 2007
2
Building a Coalition
2000 General Assembly urges Rhode Island cities and towns to create municipal Cancer Control Task Forces.
Established partnership among American Cancer Society, RIDOH, RICAN
13 coalitions were formed.
3
Building a Coalition
Neither one focused on dispair populations.
Hispanic/Latinos are the majority of the minority groups in RI, representing almost 12% of the overall population.
Among the Hispanic/Latino population, Cancer was the leading cost of death during the period of 1999-2004 in the State of Rhode Island.
4
Building a Coalition
The Formation of the Latino Cancer Control Task Force will help: to determine the nature of cancer challenge in
our community, to examine its causes, and to identify resources, gaps and opportunities,
in order to develop prioritized strategies that will diminish the cancer deaths among the Latino community in our state.
5
Building a Coalition
October 20, 2005, The Latino Cancer Control Task Force
(LCCTF) was created as a volunteer-based Community group formed
in response to the need to reduce the leading causes of cancer morbidity and
mortality among Hispanic/Latinos in Rhode Island.
6
The Latino Cancer Control Task Force Mission Statement
The Latino Cancer Control Task Force aims to reduce the impact of cancer in the Latino
community in Rhode Island
by facilitating cancer prevention through outreach, public education, awareness, early
detection, access to care and advocacy,
and improving care and quality of life for cancer patients, their families, and caregivers.
7
The Latino Cancer Control Task ForceGoals and Objectives
Advocacy. Being vigorous advocates for cancer control, supporting public policy initiatives and research, and developing strategic alliances with governmental agencies, hospitals, nongovernmental health promotion organizations, health professionals, the community, and the media.
Outreach. Providing outreach targeting the different populations, institutions, providers, policy makers, advocates, community leaders and organizations to increase knowledge and awareness of cancer issues affecting Latinos.
8
The Latino Cancer Control Task Force Goals and Objectives
Education. Preventing cancer by increasing knowledge and awareness of cancer and by encouraging healthier behaviors.
Services. Promoting the early detection of cancer through public education and access to screenings and treatment.
Quality of life. Improving patients' quality of life and minimizing their suffering through education, support, and palliative care.
9
The Latino Cancer Control Structure
Co-Chairs(2)
Data AnalysisWorkgroup
OutreachWorkgroup
Policy & Advocacy
Workgroup
MediaWorkgroup
Secretary Treasurer
10
LCCTF Projects
Conduct an assessment on what resources are available to the Hispanic/Latino population.
Assess how data is collected and interpreted by regulatory offices.
Bring together Latino health professionals to educate and create community awareness on the issues of cancer prevention and early detection.
Trough our Advocacy workgroup support American Cancer Society Legislative Policy Priorities.
Ensure fair access to screenings and treatment.
11
LCCTF Accomplishments
Membership: LCCTF membership represents the vast diversity of Latinos in RI.
Data Analysis: Data Analysis workgroup conducted a survey to all RI Hospitals.
1st. Annual Conference “Mujeres Hablemos Claro! La Salud del Seno” 183 registered, 126 attended, 60 new volunteers, 13 “De Amiga a Amiga” volunteers trained.
Legislation Introduced by one of LCCTF members Senator Juan Pichardo, asking to increase the funds for the WCSP.
12
LCCTF Data Systems Project
Assess how data is collected and interpreted by regulatory offices
The Rhode Island Cancer Registry System Study
13
The RICR System Study -Objectives
Conduct an assessment of the Rhode Island Cancer Registry (RICR) System
Determine how race and ethnicity information of cancer patients is collected and reported
Identify strengths, limitations and opportunities for improving CR information quality and data utilization for population targeting and outreach
14
Main Questions
What are the start and end-points of the RI CR?
What is the guideline?
Is there compliance with OMB 15?What are the implications of non-uniform reporting?
Other study findingsCan under-reporting be corrected?
15
Start and End-Points - RICR
Cancer Patients
DATA SYSTEM
COLLECTION AGGREGATION LOCAL, REGIONAL AND NATIONAL REPORTING
Cancer Patients/Cancer
Families
16
What is the Guideline?
The Rhode Island Department of Health requires healthproviders to collect the following demographic information about their patients:
What is your ethnic background? Hispanic/Latino Not Hispanic/Latino
What is your race? (please indicate all races that apply) American Indian or Alaskan Native
Asian Black or African American Native Hawaiian or other Pacific Islander White
17
OMB 15
Is there compliance in the collection and reporting of race and ethnicity?
18
RICRS Assessment - Methods
Hospital Survey 14 acute care hospitals13 cancer registries hospital cancer registry data not a start or end-point
Key Informant Interviews3 key informantspublic health, health care industry and national voluntary health organization
19
Hospital Cancer Registry Survey
Unit of Analysis: hospitals (information collected via questionnaire)
Population of Interest: Rhode Islanders with a diagnosis of primary cancer
Main Topics: forms used for cancer patient intake, collection of cancer risk factors and race/ethnicity information, content of database and access to cancer registry data, feasibility of CR and MR linkage, frequency of reports and organizations receiving reports (22 questions)
20
Participating Hospitals (N=14)
Kent Hospital Landmark Medical Center Memorial Hospital of Rhode Island Miriam Hospital Naval Health Care New England Newport Hospital Rhode Island Hospital Roger Williams Medical Center South County Hospital St. Joseph Hospital Our Lady of Fatima Hospital VA Medical Center Westerly Hospital Women & Infants Hospital
21
Key Informant Interviews
Unit of Analysis: individual expertise in cancer data systems (information collected via questionnaire)
Population of Interest: US population with a diagnosis of primary cancer
Main Topics: reporting organizations, types/ format of information reported, risk factor and race/ethnicity information quality, methods for adjusting under-reporting, OMB compliance, database content and access to cancer registry data, feasibility of CR and MR linkage, frequency of reports and agencies targeted (26 questions)
22
Key Informants (N=3)
John Fulton, PhD Director, Rhode Island Cancer Registry Associate Director of Health Rhode Island Department of Health
David Rousseau, PhD Director, Cancer Information Systems Hospital Association of Rhode Island
Jimmy Parson, PhD Research and Analysis Manager American Cancer Society, NHO
23
Analysis
Hospital Survey Since sample size was small, results are presented as frequencies and percents Because some questions asked for more than
1 response, some figures exceed the total number of expected responses
Responses were converted into ordinal scales (i.e.; all=100%; most=70-99%; some=40-69%; a few=1-39%; none=0%) Ordinal scales were grouped by topic in order
to summarize findings
24
Analysis
Key Informant InterviewsEmphasis set on the qualitative aspects of informationResults not presented in frequencies or percents Information used to gain a better insight into
hospital survey results and inform discussion of findings and recommendations to 1) help improve the quality of cancer registries and 2) translate findings into improved outreach
practices
25
Main Results -Hospital Survey
Summary 14 Rhode Island hospitals have cancer registries Requested participation of hospital cancer
registrars Respondents signed consent form 1 initial mailing and two respondent follow-ups 11 hospital cancer registries responded (79%
response rate) Findings presented exclude non-respondents Respondent follow-up ended 04-16-07 2 hospitals share the same reporting system
26
Main Results -Hospital Survey (cont.)
Race/Ethnicity/Country of Origin How is the race of a cancer patient determined? (this was a multiple response question)
a. In 4 hospitals (36%) patient self-reports race
b. In 5 hospitals (45%) person filling form asks patient
c. In 1 hospital (9%) person filling form makes a guess
d. In 4 hospitals (36%) information obtained from MR
e. 1 hospital (9%) uses medical history/physical exam 2 hospitals use a combination of methods b and d 1 hospital use a combination of methods b and c
27
Main Results -Hospital Survey (cont.)
Race/Ethnicity/Country of Origin
How is the ethnicity of a cancer patient determined? (multiple response question)
a. 3 hospitals (27%) present the patient with a standard form and the question “Are you from Hispanic or Latino origin”
b. 6 hospitals (56%) ask patients about their ethnicity in a non-standard way
c. 2 hospitals (18%) reported “unknown”
28
Key Informant Main FindingsTOPIC HARI RI CR ACS
Race/ethnicity yes yes yes
# of races most report 1 race most report 1 race (“can most report 1 racereported report up to six”)
Information on no some; “this is a variable in nohow is race the NCAACCR data set, butdetermined? HEALTH does not require it”
Information on no no a fewhow ethnicity isdetermined?
Do you provide “Race and ethnicity When directed by feds “We only look at race/
guidance to treated like all other When required by state ethnicity data forcomply with data items required When requested by hospitals screening data and data OMB 15? by law” When required by RI HARI coming from CDC”
Target year for no “It’s being discussed but no responsehelping partners no date yet” achieve OMB 15 compliance?
29
Start and End-Points - RICR
Naval HC NE
Miriam H.
Memorial H RI
Landmark MC
Kent H.
Newport H.
Rhode Island H.
R. Williams MC
South County H.
St .Joseph H.
Our Lady of Fatima
VA MC
Westerly H.
Women & Infants.
Hospitals CRs1
2
3
4
5
6
7
8
9
10
11
12
13
HARI
RI CR
6 states
pathology labs, surgical centers
21st Century Oncology Services
Cancer Patients
CDC
NAACCR
CBTRUS
CDC
NAACCR
IACR
ACS
NCQA
Colorectal Screenings in Health Plans
ALA
BRFSSYBRFS
NPCR
ACS Divisions
ACS Management
Cancer Patients/Cancer
Families?
30
Compliance with OMB 15?
Findings from the hospital cancer registry survey indicated lack of uniform collection of information on race and ethnicity.
Only a few hospitals ask patients to self-report their race (27%) and ethnicity (27%) according to the guideline Only a few hospitals (36%) collect information on 2 or more races
The Key Informant Interview revealed that most cancer data sources only report 1 race
There is no target date yet in RI for achieving OMB 15 compliance with cancer data reporting
31
Summary of Findings 1. Use of Intake Forms (IFs) specific to cancer2. Use of IFs (cancer-specific and general)3. Use of IFs to obtain cancer risk factor (CRF) information4. Use of other forms to obtain CRF information5. Collection of CRF information from all sources6. Is reporting of CRF information a RI CR requirement?7. Race information obtained at point of entry (POE)8. Race information obtained from other sources9. Ethnicity information obtained at POE10. Ethnicity information obtained from other sources11. RI CR mechanism to monitor OMB 15 compliance?12. Collection of information on country of origin13. IF/MR linkage14. RI CR/MR linkage15. Patient self-reporting of race and ethnicity16. Collection of information of two or more races17. Reporting of two or more races18. Target date for OMB 15 compliance?19. Cancer data available/IRB process in place
32
Summary of Findings 1.
2.
3. 4.
5.
6. NO 7.
8. 9.
10.11. NO12.
13.14.
15.
16.
17.
18. NO
19.
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
??
45%91%
30%60%
90%
91%
60%40%
56%44%
12%100%
9%
37%27%
36%
Hospital Cancer Registry SurveyKey Informant Interview
33
Implications of Non-Compliance
Undercount of multi-racial ethnic groups; over count of non multi-racial ethnic groupsUnderestimates in cancer prevalence, incidence and mortalityProblem may not be limited to the RI CRS; other RI/national data sets may be affectedDifficult targeting and outreach of multi- racial ethnic groupsMisdirecting resources for targeting/outreachPotential for unsound public health practice
34
Can the Problem be Fixed?
Our recommendations:
Improve data quality at the point of entry and monitor data quality collection and reporting on key variables including race and ethnicity
In the interim, promote use and refinement of the Spanish Surname Algorithm to determine the extent of the undercount of Hispanic cancer cases and institutionalize dissemination of more reliable cancer statistics
35
Apply the Guideline Please
36
Contact Information
Alvaro M Tinajero, MD, MPH, [email protected]@[email protected]
Mercedes (Betty) [email protected]